The health ministry has notified the inclusion of coronary stents in the National List of Essential Medicines(NLEM), 2022, a move that will help make these life-saving medical devices more affordable. The move is based on the recommendations by an expert committee constituted to review the inclusion of stents in the list based on requirement. The National Pharmaceutical Pricing Authority (NPPA) will now fix the price of coronary stents.
Posted from: this blog via Microsoft Power Automate.